← Back to headlines
Ozempic-Maker Novo Nordisk Accuses Eli Lilly of False Advertising
Novo Nordisk, the maker of Ozempic, has initiated legal action against rival pharmaceutical company Eli Lilly, alleging that its advertisements are misleading, a claim Eli Lilly denies.
21 Jul, 15:20 — 21 Jul, 15:20
Sources
Showing 1 of 1 sources
Related Stories
Abercrombie & Fitch Beats Q2 Earnings Expectations and Raises Full-Year Guidance
21m ago
Biohaven Shares Rise Following Major Licensing Deal
27m ago
Nigeria Launches 100 Electric Buses for Federal Civil Servants
28m ago
Leveraged and Momentum Trading Fuels Roller Coaster Volatility in Software Equities
32m ago